Napro Pharma

Napro Pharma is a Norwegian pharmaceutical company specializing in the development and manufacture of high-purity marine-derived lipids and Omega-3 fatty acids. Based in Brattvåg, the company operates a state-of-the-art GMP-certified manufacturing facility that utilizes advanced molecular distillation and thin-film evaporation technologies. Napro Pharma produces both Active Pharmaceutical Ingredients (APIs) and high-end nutraceutical concentrates, serving the global pharmaceutical, clinical nutrition, and supplement markets. The company is a key subsidiary of the Hofseth Group, benefiting from a vertically integrated supply chain that ensures the sustainability and traceability of its raw materials. Their expertise in lipid chemistry and purification allows them to provide specialized solutions for cardiovascular health and clinical nutrition.